Likewise, an increasing trend in BM frequencies was also shown among evaluable patients in 3LT and 4LT settings as lines advancing.
← all excerpts
Real-world management strategies and clinical outcomes of metastatic HER2-positive breast cancer in Greece in the second-line setting and beyond (the togetHER study).
1
—
—